Dry Powder Inhaler Devices Report Include Key-Players, Clinical Trials, Analysis
Posted by Deeksha on June 6th, 2019
It has been observed that, the global market for Dry Powder Inhaler Devices would be experiencing steady growth marked in million US$ by 2025. Such advancements can be attributed to the efforts put in by prime manufacturers operating in the global Dry Powder Inhaler Devices market during the period. All such statistics and figures are carefully enclosed in a recently uploaded research report titled “Dry Powder Inhaler Devices” - Medical Devices Pipeline Assessment, 2019, onto its broad online database. Readers are enlightened about different aspects associated to the global Dry Powder Inhaler Devices which covers Pipeline Stages, Clinical Trials and other developmental activities.
Get Sample Copy of this Report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2374717
Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2019
Summary
GlobalData's Medical Devices sector report, Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Dry Powder Inhaler Devices currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dry Powder Inhaler Devices pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
Scope
- Extensive coverage of the Dry Powder Inhaler Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Dry Powder Inhaler Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Dry Powder Inhaler Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date.
Request TOC of the Report @ https://www.marketresearchhub.com/report/dry-powder-inhaler-devices-medical-devices-pipeline-assessment-2019-report.html
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Dry Powder Inhaler Devices Overview
3 Products under Development
3.1 Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
3.2 Dry Powder Inhaler Devices - Pipeline Products by Territory
3.3 Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path
3.4 Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date
3.5 Dry Powder Inhaler Devices - Ongoing Clinical Trials
4 Dry Powder Inhaler Devices - Pipeline Products under Development by Companies
4.1 Dry Powder Inhaler Devices Companies - Pipeline Products by Stage of Development
4.2 Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
5 Dry Powder Inhaler Devices Companies and Product Overview
5.1 Acorda Therapeutics Inc Company Overview
5.2 Adamis Pharmaceuticals Corp Company Overview
5.3 Advent Pharmaceuticals Pty Ltd Company Overview
5.4 Aespira Ltd. Company Overview
5.5 AKELA Pharma Inc. (Inactive) Company Overview
5.6 AstraZeneca Plc Company Overview
5.7 Bayer AG Company Overview
5.8 Boehringer Ingelheim GmbH Company Overview
5.9 Circassia Pharmaceuticals Plc Company Overview
5.10 Eli Lilly and Co Company Overview
5.11 GlaxoSmithKline Plc Company Overview
5.12 Lupin Pharmaceuticals Inc Company Overview
5.13 MannKind Corp Company Overview
5.14 Monash University Company Overview
5.15 Nektar Therapeutics Company Overview
5.16 Ology Bioservices Inc Company Overview
5.17 OPKO Health Inc Company Overview
5.18 OtiTopic LLC Company Overview
5.19 Pharmaxis Ltd Company Overview
5.20 Respira Therapeutics Inc Company Overview
5.21 Sandoz International GmbH Company Overview
5.22 Sheffield Hallam University Company Overview
5.23 Spyryx Biosciences Inc Company Overview
5.24 Sun Pharma Advanced Research Company Ltd Company Overview
5.25 Teva Pharmaceutical Industries Ltd Company Overview
5.26 University of Kansas Company Overview
5.27 University of Sydney Company Overview
5.28 University of Texas Medical Branch at Galveston Company Overview
5.29 Vectura Group Plc Company Overview
5.30 Verona Pharma Plc Company Overview
5.31 Virginia Commonwealth University Company Overview
6 Dry Powder Inhaler Devices- Recent Developments
6.1 May 02, 2019: Teva reports first quarter 2019 financial results
6.2 May 01, 2019: GSK delivers sales of 7.7 billion +6% AER, +5% CER
6.3 Apr 25, 2019: 3M reports first-quarter 2019 results; company initiates restructuring
Continued………..#@
